Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
36 /100
MEDIUM RISK
Score updated Oct 13, 2026

MDGL — Madrigal Pharmaceuticals, Inc. Dilution Risk Tracker

Track MDGL dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track MDGL — Get alerts when the score changes →

As of October 13, 2026, Madrigal Pharmaceuticals, Inc. (MDGL) has a DilutionWatch DilutionScore of 36/100, rated MEDIUM dilution risk. Madrigal Pharmaceuticals, Inc. has a market capitalization of $10.79B, 23.10M shares outstanding, 384 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
65
📊 Float Risk
45
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 7%
💰 Capital Raise model 15%
• Under 12 months cash (7mo)
🔔 Track MDGL — Get forecast alerts →

Market Data

Market Cap$10.79B
Shares Outstanding23.10M
Float12.91M
Cash$292.73M
Debt$340.79M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore36/100DilutionWatch score record
Shares Outstanding23.10MVerified float table or market cache
Public Float12.91MVerified float table or market cache
Market Cap$10.79BMarket data cache
Cash Runway7.2 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 24.9% shares (2026Q1 vs prior)
384 institutional holders · 30.98M shares
#1 JANUS HENDERSON GROUP PLC 4.04M shares
#2 Avoro Capital Advisors LLC 3.63M shares
#3 BAKER BROS. ADVISORS LP 2.14M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest2.40M
Days to Cover9.8
% of Float18.6%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-02-19
xbrl XBRL CONVERTIBLE 2023-03-03
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual MDGL Dilution Snapshot

Madrigal Pharmaceuticals, Inc. (MDGL) has a DilutionScore of 36/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

MDGL's DilutionScore is currently 36/100 (Medium risk), with 1 score change tracked over 89 days. The score deteriorated from 50/100 (Medium risk).

Period Score Risk Level Duration
Aug 14 – Oct 13, 202636/100MEDIUM60 days
Jul 16 – Aug 13, 202650/100MEDIUM29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

MDGL shares outstanding have increased 1.5% from 22.71M (Mar 2026) to 23.06M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 27, 202623.06M12.91M▲ 0.06%
May 25, 202623.06M12.90M▼ 0.01%
May 22, 202623.06M12.90M▼ 0.09%
May 19, 202623.06M12.91M▲ 2.42%
May 10, 202623.06M12.61M▼ 12.85%
May 09, 202623.06M14.46M▲ 15.80%
Mar 23, 202622.94M12.49M▲ 0.07%
Mar 05, 202622.71M12.48M▼ 0.01%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track MDGL Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment MDGL files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking MDGL — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for MDGL
MDGL FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.